CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 4,22 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed
Journal for ImmunoTherapy of Cancer
United Kingdom · BMJ Publishing Group
workspace_premium Q1 — Pharmacology verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Journal for ImmunoTherapy of Cancer

Journal for ImmunoTherapy of Cancer is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 136. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1694 €. The scope of the journal is focused on tumour immunology, cancer immunotherapy, immunotherapy biomarkers. It has an SJR impact factor of 4,22 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 4,22.

Journal for ImmunoTherapy of Cancer focuses its scope in these topics and keywords: immunotherapy, response, cancer, tumor, t, society, patient, therapy, cell, carcinoma, ...

Publisher: BMJ Publishing Group
Category: Pharmacology
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
4,22 Q1
H-index 136
Acceptance rate pie_chart
26% Selective
Source Acceptance_Rate
Time to publication hourglass_top
8 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
1.694 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

4,22

H-index

136

Docs (year)

471

Docs 3y

1524

Total refs

20875

Cites 3y

14439

Citable 3y

1494

Cites/Doc 2y

9.1

Ref/Doc

44.32

Immediate OA

1694 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Journal for ImmunoTherapy of Cancer?

Journal for ImmunoTherapy of Cancer has an SJR of 4,22 (best quartile Q1) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 1694 EUR.

What is the acceptance rate?

The acceptance rate recorded for Journal for ImmunoTherapy of Cancer is 26%.